Endogenous kappa-opioid receptor systems regulate mesoaccumbal dopamine dynamics and vulnerability to cocaine.
about
The emerging role of trace amine-associated receptor 1 in the functional regulation of monoamine transporters and dopaminergic activityNalmefene: a new approach to the treatment of alcohol dependenceStress-induced reinstatement of cocaine seeking is mediated by the kappa opioid systemStress-induced p38 mitogen-activated protein kinase activation mediates kappa-opioid-dependent dysphoria.Social defeat stress-induced behavioral responses are mediated by the endogenous kappa opioid systemA Possible Role of Anhedonia as Common Substrate for Depression and Anxiety15 years of genetic approaches in vivo for addiction research: Opioid receptor and peptide gene knockout in mouse models of drug abuseDrug withdrawal conceptualized as a stressor.Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in HumansDynorphin Controls the Gain of an Amygdalar Anxiety CircuitRole of the dopamine transporter in the action of psychostimulants, nicotine, and other drugs of abuseA genetic polymorphism of the endogenous opioid dynorphin modulates monetary reward anticipation in the corticostriatal loopAblation of kappa-opioid receptors from brain dopamine neurons has anxiolytic-like effects and enhances cocaine-induced plasticityKappa-opioid receptor signaling in the striatum as a potential modulator of dopamine transmission in cocaine dependenceMolecular and genetic substrates linking stress and addictionThe effects of kappa-opioid receptor ligands on prepulse inhibition and CRF-induced prepulse inhibition deficits in the rat.Peptide kappa opioid receptor ligands: potential for drug development.Motivational systems in adolescence: possible implications for age differences in substance abuse and other risk-taking behaviors.kappa-Opioid receptors control the metabolic response to a high-energy diet in miceThe role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuseOverview of brain microdialysisSalvinorin A regulates dopamine transporter function via a kappa opioid receptor and ERK1/2-dependent mechanism.Salvinorin A analogs and other κ-opioid receptor compounds as treatments for cocaine abuse.Kappa opioids selectively control dopaminergic neurons projecting to the prefrontal cortexBasolateral amygdala-driven augmentation of medial prefrontal cortex GABAergic neurotransmission in response to environmental stimuli associated with cocaine administration.Blockade of kappa opioid receptors attenuates the development of depressive-like behaviors induced by cocaine withdrawal in rats.Kappa opioid receptor signaling in the brain: Circuitry and implications for treatment.Lack of genotype effect on D1, D2 receptors and dopamine transporter binding in triple MOP-, DOP-, and KOP-opioid receptor knockout mice of three different genetic backgroundsA single injection of a novel κ opioid receptor agonist salvinorin A attenuates the expression of cocaine-induced behavioral sensitization in rats.Kappa-opioid receptor modulation of accumbal dopamine concentration during operant ethanol self-administration.The endogenous opioid system in cocaine addiction: what lessons have opioid peptide and receptor knockout mice taught us?Kappa Opioid Receptor-Mediated Disruption of Novel Object Recognition: Relevance for Psychostimulant Treatment.Dysregulation of kappa-opioid receptor systems by chronic nicotine modulate the nicotine withdrawal syndrome in an age-dependent manner.Emerging pharmacological strategies in the fight against cocaine addiction.Opiate addiction and cocaine addiction: underlying molecular neurobiology and genetics.Properties and opioid inhibition of mesolimbic dopamine neurons vary according to target location.Kappa opioid inhibition of somatodendritic dopamine inhibitory postsynaptic currents.Endogenous kappa-opioid receptor systems inhibit hyperalgesia associated with localized peripheral inflammationExposure to the selective kappa-opioid receptor agonist salvinorin A modulates the behavioral and molecular effects of cocaine in rats.Repeated exposure to moderate doses of ethanol augments hippocampal glutamate neurotransmission by increasing release.
P2860
Q22242368-BDF46596-1038-42C5-8169-3E4CCC301430Q24564708-CFC1FB3B-633C-4530-A61E-7136932F3C91Q24646604-CE15EAF2-95D4-4FFC-826E-C784F97BEA23Q24655307-D631C635-04A3-4BF0-BFDE-DE2DFAE730D5Q24685275-F6CDA1D6-7E0C-4725-9FF5-143A2CBCF545Q26752718-14498081-8A79-4D29-A961-F383D0E1770EQ26824667-9F9DC02A-118B-4634-AC51-6369ED9AEAEAQ26997989-E139708D-8294-4FB5-B3F5-B9B1C1A5C657Q27300685-C0472807-3F03-42B7-A8FB-F7408D2C665CQ27319741-6CACFFE7-22E3-4419-89D0-AD8CC06145D2Q28306056-9C22C27A-AAE3-45F2-A704-EC1E8FE4B5F9Q28540133-5C8CE7C9-B71B-4710-86D0-5D8327BE2EC5Q30435816-60F143C6-1D0E-4C12-8FC2-11350C517993Q30453617-3DBE377E-E01E-43C4-97CE-C404FC9B06A2Q30476986-0FE1CAC5-8973-4B5A-8084-EC034148FEB8Q30479463-86FEFBCD-56CD-4919-AF65-4A763D31CF0BQ33442900-E54DE9B0-B964-40DB-8D39-4CBBB7034938Q33624258-E93DED3E-F9BC-4789-B524-B46B096CD480Q33752916-D375302A-67A5-4648-9594-4C1D35C45089Q33890721-04F8E0D0-3BCC-4003-9734-E14DFECD25E1Q34190861-870B1468-60CE-4AAE-8E0D-89C44C2C1108Q34302349-A244F090-FD52-4812-9024-3C19551F82ABQ34401390-AA014E66-A59F-48B4-8C5A-279311866986Q34479813-98EBC61D-2613-492F-A1B5-36C502A4AF09Q35171337-9D507414-8762-41C7-8031-FC3577257E18Q35375156-F921CB41-6727-4949-A327-5EBEE247F357Q35736840-198B80B5-0CC3-4497-8E89-B19C1CB817B3Q35765802-7557D5A7-0D62-4CB0-8839-93DEFFD70A74Q35837572-DDF45372-0FD4-4DD0-9395-4B9DD265BCD9Q35985799-75CCEB92-ACFC-4BB6-80FE-4285A2006462Q36110480-B3758E16-E8E9-4DCF-AE9F-4F72B503EA3AQ36163631-0331322B-A4FB-405C-AA4D-4EAD9C9362D0Q36350809-AE16C558-021C-405E-BBF5-55EA331C76E1Q36407408-9BE16E31-38C9-4EE5-87AC-4C78496FA82CQ36499673-3267AB7F-81D1-48F6-BE0F-0050CE4B52D8Q36758556-E74B87A0-C95D-40C1-BCEC-2D717D95C841Q36787595-0FEF51B5-6E95-451A-A01A-63D01CAAA153Q36909179-DAB77A3F-297F-42BB-AECC-07130D3E85FBQ36930731-649B0E9A-ADAE-4483-ABC0-FEEC53F02C94Q36935595-F953B691-D24F-410C-9CA9-CB0D8D49C523
P2860
Endogenous kappa-opioid receptor systems regulate mesoaccumbal dopamine dynamics and vulnerability to cocaine.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Endogenous kappa-opioid recept ...... and vulnerability to cocaine.
@ast
Endogenous kappa-opioid recept ...... and vulnerability to cocaine.
@en
Endogenous kappa-opioid recept ...... and vulnerability to cocaine.
@nl
type
label
Endogenous kappa-opioid recept ...... and vulnerability to cocaine.
@ast
Endogenous kappa-opioid recept ...... and vulnerability to cocaine.
@en
Endogenous kappa-opioid recept ...... and vulnerability to cocaine.
@nl
prefLabel
Endogenous kappa-opioid recept ...... and vulnerability to cocaine.
@ast
Endogenous kappa-opioid recept ...... and vulnerability to cocaine.
@en
Endogenous kappa-opioid recept ...... and vulnerability to cocaine.
@nl
P2093
P2860
P1476
Endogenous kappa-opioid recept ...... and vulnerability to cocaine.
@en
P2093
Elizabeth A Bolan
John E Pintar
Jose Moron
Toni S Shippenberg
Traci Czyzyk
Vladimir I Chefer
P2860
P304
P356
10.1523/JNEUROSCI.0854-05.2005
P407
P577
2005-05-01T00:00:00Z